Davis MM - Search Results

1

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.

Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, Voillet V, Duvvuri VR, Scherler K, Troisch P, Baloni P, Qin G, Smith B, Kornilov SA, Rostomily C, Xu A, Li J, Dong S, Rothchild A, Zhou J, Murray K, Edmark R, Hong S, Heath JE, Earls J, Zhang R, Xie J, Li S, Roper R, Jones L, Zhou Y, Rowen L, Liu R, Mackay S, O'Mahony DS, Dale CR, Wallick JA, Algren HA, Zager MA; ISB-Swedish COVID19 Biobanking Unit; Wei W, Price ND, Huang S, Subramanian N, Wang K, Magis AT, Hadlock JJ, Hood L, Aderem A, Bluestone JA, Lanier LL, Greenberg PD, Gottardo R, Davis MM, Goldman JD, Heath JR. Su Y, et al. Among authors: davis mm. Cell. 2020 Dec 10;183(6):1479-1495.e20. doi: 10.1016/j.cell.2020.10.037. Epub 2020 Oct 28. Cell. 2020. PMID: 33171100 Free PMC article. Clinical Trial.

2

Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain.

Loh EY, Elliott JF, Cwirla S, Lanier LL, Davis MM. Loh EY, et al. Among authors: davis mm. Science. 1989 Jan 13;243(4888):217-20. doi: 10.1126/science.2463672. Science. 1989. PMID: 2463672

3

Identification and sequence of a fourth human T cell antigen receptor chain.

Loh EY, Lanier LL, Turck CW, Littman DR, Davis MM, Chien YH, Weiss A. Loh EY, et al. Among authors: davis mm. Nature. 1987 Dec 10-16;330(6148):569-72. doi: 10.1038/330569a0. Nature. 1987. PMID: 2825032

4

Immunoglobulin class switching: developmentally regulated DNA rearrangements during differentiation.

Davis MM, Kim SK, Hood L. Davis MM, et al. Cell. 1980 Nov;22(1 Pt 1):1-2. doi: 10.1016/0092-8674(80)90145-2. Cell. 1980. PMID: 6775814 Review. No abstract available.

5

The nature of major histocompatibility complex recognition by gamma delta T cells.

Schild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, Bluestone JA, Matis L, Draper RK, Chien YH. Schild H, et al. Among authors: davis mm. Cell. 1994 Jan 14;76(1):29-37. doi: 10.1016/0092-8674(94)90170-8. Cell. 1994. PMID: 8287478

6

Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.

Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Yee C, et al. Among authors: davis mm. J Immunol. 1999 Feb 15;162(4):2227-34. J Immunol. 1999. PMID: 9973498

7

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD. Yee C, et al. Among authors: davis mm. J Exp Med. 2000 Dec 4;192(11):1637-44. doi: 10.1084/jem.192.11.1637. J Exp Med. 2000. PMID: 11104805 Free PMC article.

8

Detection and characterization of cellular immune responses using peptide-MHC microarrays.

Soen Y, Chen DS, Kraft DL, Davis MM, Brown PO. Soen Y, et al. Among authors: davis mm. PLoS Biol. 2003 Dec;1(3):E65. doi: 10.1371/journal.pbio.0000065. Epub 2003 Dec 22. PLoS Biol. 2003. PMID: 14691537 Free PMC article.

9

Cellular immunotherapy: antigen recognition is just the beginning.

Chen DS, Davis MM. Chen DS, et al. Among authors: davis mm. Springer Semin Immunopathol. 2005 Jun;27(1):119-27. doi: 10.1007/s00281-005-0200-z. Epub 2005 Apr 16. Springer Semin Immunopathol. 2005. PMID: 15834723 Review.

10

Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.

Chen DS, Soen Y, Stuge TB, Lee PP, Weber JS, Brown PO, Davis MM. Chen DS, et al. Among authors: davis mm. PLoS Med. 2005 Oct;2(10):e265. doi: 10.1371/journal.pmed.0020265. Epub 2005 Sep 20. PLoS Med. 2005. PMID: 16162034 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,146 results

Search Page